Inhaled glucocorticoids and COPD exacerbations.

Inhaled glucocorticoids and COPD exacerbations.

Detalhes bibliográficos
Principais autores:	Brightling, C, Pavord, I, Bafadhel, M
Formato:	Journal article
Idioma:	English
Publicado em:	2015

Registros relacionados

Inhaled corticosteroids in COPD.
por: Brightling, C, et al.
Publicado em: (1999)

Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations
por: McKeever, T, et al.
Publicado em: (2018)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
por: Bafadhel, M, et al.
Publicado em: (2014)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
por: Saha, S, et al.
Publicado em: (2006)

Inhaled corticosteroids in COPD (multiple letters) [1]
por: Hart, S, et al.
Publicado em: (1999)

Aspergillus fumigatus during stable state and exacerbations of COPD.
por: Bafadhel, M, et al.
Publicado em: (2014)

The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
por: Russell, R, et al.
Publicado em: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, S, et al.
Publicado em: (2018)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
por: Barker, B, et al.
Publicado em: (2015)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
por: Bafadhel, M, et al.
Publicado em: (2016)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui SH, et al.
Publicado em: (2018-11-01)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
por: Eltboli, O, et al.
Publicado em: (2014)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
por: Jose R. Jardim, et al.
Publicado em: (2019-04-01)

Exacerbations of COPD
por: Pavord ID, et al.
Publicado em: (2016-02-01)

Lung microbiome dynamics in COPD exacerbations
por: Wang, Z, et al.
Publicado em: (2016)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
por: Russell, R, et al.
Publicado em: (2019)

Is it time to give up on "self-management" of COPD exacerbations?
por: Ramakrishnan, S, et al.
Publicado em: (2020)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
por: Siva, R, et al.
Publicado em: (2014)

COPD exacerbation phenotypes: The next frontier
por: Moran, A, et al.
Publicado em: (2019)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
por: Bafadhel M, et al.
Publicado em: (2015-06-01)

Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles
por: Ghebre, M, et al.
Publicado em: (2018)

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
por: Bafadhel, M, et al.
Publicado em: (2011)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
por: Russell REK, et al.
Publicado em: (2019-05-01)

Benralizumab for the prevention of COPD exacerbations
por: Criner, G, et al.
Publicado em: (2019)

The role of CT scanning in multidimensional phenotyping of COPD.
por: Bafadhel, M, et al.
Publicado em: (2011)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
por: Helen F. Ashdown, et al.
Publicado em: (2021-02-01)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
por: Siva R, et al.
Publicado em: (2014-02-01)

Use of dry powder inhalers in acute exacerbations of asthma and COPD
por: Olof Selroos, et al.
Publicado em: (2009-04-01)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
por: Siva, R, et al.
Publicado em: (2007)

Prednisolone response in patients with COPD.
por: Pavord, I, et al.
Publicado em: (2004)

Eosinophils in COPD: just another biomarker?
por: Bafadhel, M, et al.
Publicado em: (2017)

Characterising non-eosinophilic COPD
por: Hambleton, K, et al.
Publicado em: (2015)

Cognitive function and inhaler technique following recovery from exacerbations of COPD
por: Benjamin E. Henkle, et al.
Publicado em: (2023-05-01)

COPD exacerbations: transforming outcomes through research
por: Hurst, JR, et al.
Publicado em: (2018)

Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
por: McKeever, T, et al.
Publicado em: (2018)

Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study
por: Jing Zhang, et al.
Publicado em: (2018-04-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
por: Kerkhof, M, et al.
Publicado em: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
por: Djamin, R, et al.
Publicado em: (2019)

Renaming COPD exacerbations: the UK respiratory nursing perspective
por: Christine Mwasuku, et al.
Publicado em: (2021-09-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo J, et al.
Publicado em: (2019-04-01)